David Cole, PhDCollaboration Research Group Leader at Immunocore
Dr David Cole currently leads Collaboration Research at Immunocore, a privately funded biotech just outside of Oxford that is developing novel bispecific T cell engagers using engineered T cell receptor technology. Before moving to Immunocore in 2017, David spent a number of years in academia, completing his PhD at Oxford University in 2007, before setting up his own laboratory at Cardiff University in 2009. During his academic career, David used a variety of molecular approaches (X-ray crystallography, biophysics, protein engineering) to better understand the nature of T cell antigen recognition, which is governed by the interaction between the T cell receptor and peptide-human leukocyte antigen. In his current role at Immunocore, he is now applying this fundamental understanding of T cell receptors to help develop novel drugs to treat cancer.